Dalfampridine Side Effects
Some side effects of dalfampridine may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to dalfampridine: oral tablet extended release
Get emergency medical help if you have any of these signs of an allergic reaction while taking dalfampridine: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop taking dalfampridine and call your doctor at once if you have a serious side effect such as:
-
seizure (convulsions);
-
pain or burning when you urinate;
-
problems with balance;
-
numbness, burning pain, or tingly feeling;
-
relapse or worsening of MS symptoms;
Less serious side effects of dalfampridine may include:
-
headache, dizziness;
-
sleep problems (insomnia);
-
nausea, constipation, upset stomach;
-
weakness;
-
stuffy nose, sinus pain, sore throat; or
-
back pain.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to dalfampridine: oral tablet extended release
Renal
Renal side effects including urinary tract infection (12%) have been reported.
General
General side effects including insomnia (9%) and asthenia (7%) have been reported.
Nervous system
Nervous system side effects including dizziness (7%), headache (7%), balance disorder (5%), multiple sclerosis relapse (4%), and paresthesia (4%) have been reported.
Gastrointestinal
Gastrointestinal side effects including nausea (7%), constipation (3%), dyspepsia (2%), and pharyngolaryngeal pain (2%) have been reported.
Musculoskeletal
Musculoskeletal side effects including back pain (5%) have been reported.
Respiratory
Respiratory side effects including nasopharyngitis (4%) have been reported.
Genitourinary
Genitourinary side effects have been have reported in animal studies which noted a significant increase in uterine polyps at the highest dose tested.
More dalfampridine resources
- dalfampridine MedFacts Consumer Leaflet (Wolters Kluwer)
- dalfampridine Advanced Consumer (Micromedex) - Includes Dosage Information
- Dalfampridine Professional Patient Advice (Wolters Kluwer)
- Dalfampridine Monograph (AHFS DI)
- Ampyra Prescribing Information (FDA)
- Ampyra Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


